These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2973669)

  • 1. Therapeutic effect of 15-deoxyspergualin on acute graft rejection detected by 31P nuclear magnetic resonance spectrography, and its effect on rat heart transplantation.
    Suzuki S; Kanashiro M; Watanabe H; Amemiya H
    Transplantation; 1988 Nov; 46(5):669-72. PubMed ID: 2973669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a new immunosuppressant, 15-deoxyspergualin, on heterotopic rat heart transplantation, in comparison with cyclosporine.
    Suzuki S; Kanashiro M; Amemiya H
    Transplantation; 1987 Oct; 44(4):483-7. PubMed ID: 3313835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 15-deoxyspergualin on rejection detected by 31P nuclear magnetic resonance spectroscopy and in vivo mechanisms of action in rat heart transplantation.
    Suzuki S; Kanashiro M; Watanabe H; Sakakibara I; Amemiya H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1094-5. PubMed ID: 2523115
    [No Abstract]   [Full Text] [Related]  

  • 4. Rescue therapy for acute rejection using 15-deoxyspergualin (DSG) in combination with superoxide dismutase (SOD) on cardiac allografts in rats.
    Suzuki S; Kanashiro M; Hayashi R; Amemiya H
    Transpl Int; 1992; 5 Suppl 1():S547-51. PubMed ID: 14621873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation.
    Valdivia LA; Monden M; Gotoh M; Nakano Y; Tono T; Mori T
    Transplantation; 1990 Jul; 50(1):132-6. PubMed ID: 2368132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanism in rat with surviving heart allograft after short course of 15-deoxyspergualin treatment.
    Jiang H; Takahara S; Kyo M; Takano Y; Kokado Y; Ishibashi M; Sonoda T
    J Clin Lab Immunol; 1990 Jul; 32(3):131-6. PubMed ID: 1966949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The free radical scavenger S-PBN significantly prolongs DSG-mediated graft survival in experimental xenotransplantation.
    Biglarnia AR; Emanuelsson C; Quach M; Clausen F; Larsson E; Schneider MK; Tufveson G; Lorant T
    Xenotransplantation; 2012; 19(3):166-76. PubMed ID: 22702468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanisms: induction of heart allograft survival in rats by 15-deoxyspergualin.
    Jiang H; Takahara S; Kyo M; Takano Y; Kameoka H; Kokado Y; Ishibashi M; Okuyama A; Sonoda T
    Transpl Int; 1992; 5 Suppl 1():S497-500. PubMed ID: 14621858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor cells induced by donor-specific transfusion and deoxyspergualin in rat cardiac xenografts.
    Valdivia LA; Monden M; Gotoh M; Tono T; Nakano Y; Mori T
    Transplantation; 1991 Oct; 52(4):594-9. PubMed ID: 1833863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The superior effect of the combination of FK 506 and deoxyspergualin on rat cardiac allograft survival.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transpl Int; 1994 Aug; 7(5):315-8. PubMed ID: 7527637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of donor-specific blood transfusion and a short course of deoxyspergualin in rat kidney transplantation.
    Tanabe K; Yasuo M; Nemoto K; Takahashi K; Toma H; Ota K
    Transpl Int; 1996; 9(4):353-8. PubMed ID: 8819269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological analysis of rat renal transplant recipients exhibiting long-term survival following treatment with 15-deoxyspergualin in the early postoperative phase.
    Takeuchi I; Chikaraishi T; Seki T; Kanagawa K; Koyanagi T
    Int J Urol; 1998 Sep; 5(5):476-81. PubMed ID: 9781438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro mechanisms of cardiac allograft acceptance in the rat after short treatment with 15-deoxyspergualin.
    Jiang H; Takahara S; Kyo M; Takano Y; Kokado Y; Ishibashi M; Okuyama A; Sonoda T
    Transpl Int; 1992 Jul; 5(3):139-44. PubMed ID: 1387530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rescue effect of 15-deoxyspergualin for acute rejection on heart transplantation--using a rat model].
    Bonkohara Y; Hachida M; Nonoyama M; Hoshi H; Imamaki M; Saito S; Koyanagi H
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Jan; 42(1):61-8. PubMed ID: 8308384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
    Hancock WW; Miyatake T; Koyamada N; Kut JP; Soares M; Russell ME; Bach FH; Sayegh MH
    Transplantation; 1997 Sep; 64(5):696-704. PubMed ID: 9311705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of deoxyspergualin (DSG) on rejection and graft-versus-host disease (GVHD) after small bowel transplantation.
    Makabe M; Tanaka S; Orita K
    Transpl Int; 1994; 7 Suppl 1():S449-52. PubMed ID: 11271278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of deoxyspergualin on vascular rejection in canine kidney transplantation.
    Tanabe K; Takahashi K; Nemoto K; Okada M; Yasuo M; Hayasaka Y; Toma H; Ota K
    J Urol; 1994 Aug; 152(2 Pt 1):562-6. PubMed ID: 8015112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
    Ueda H; Itoh S; Azuma H; Isurugi K; Yutani C
    Eur Surg Res; 1994; 26(6):380-7. PubMed ID: 7851464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells.
    Pearce NW; Spinelli A; Gurley KE; Dorsch SE; Hall BM
    J Immunol; 1989 Jul; 143(2):499-506. PubMed ID: 2472441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.